Answers are grounded in this paper and cite their sources.
The ALI is still a useful predictive factor for long-term CSS in patients with ESCC. However, the prognostic value of the ALI is yet to be formally tested within randomized trials.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: